(Q30176527)

9 June 2017

Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1. (English)

1 reference

9 June 2017

D E Afar

1

1 reference

9 June 2017

L Han

2

1 reference

9 June 2017

J McLaughlin

3

1 reference

9 June 2017

S Wong

4

1 reference

9 June 2017

A Dhaka

5

1 reference

9 June 2017

K Parmar

6

1 reference

9 June 2017

N Rosenberg

7

1 reference

9 June 2017

O N Witte

8

1 reference

9 June 2017

J Colicelli

9

1 reference

9 June 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

9 June 2017

1 reference

9 June 2017

6

1 reference

9 June 2017

773-782

1 reference

9 June 2017

6

1 reference

Differential complementation of Bcr-Abl point mutants with c-Myc

9 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Signaling by ABL oncogenes through cyclin D1.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Coordinate activation of c-Src by SH3- and SH2-binding sites on a novel p130Cas-related protein, Sin.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Proline-rich sequences that bind to Src homology 3 domains with individual specificities

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Src family protein tyrosine kinases and cellular signal transduction pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Grap is a novel SH3-SH2-SH3 adaptor protein that couples tyrosine kinases to the Ras pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Protein binding and signaling properties of RIN1 suggest a unique effector function

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Acute leukaemia in bcr/abl transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Receptor tyrosine kinases and their targets

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

The molecular genetics of Philadelphia chromosome-positive leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Abl tyrosine protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Integrin regulation of c-Abl tyrosine kinase activity and cytoplasmic-nuclear transport

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

A brain serine/threonine protein kinase activated by Cdc42 and Rac1

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Protein modules and signalling networks

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Production of high-titer helper-free retroviruses by transient transfection

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Identification of a ten-amino acid proline-rich SH3 binding site

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

The viral and cellular forms of the Abelson (abl) oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Rescue of defective mitogenic signaling by D-type cyclins.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

v-abl causes hematopoietic disease distinct from that caused by bcr-abl

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Complex formation between RAS and RAF and other protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Mammalian Ras interacts directly with the serine/threonine kinase Raf

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980452-5

7 January 2021

10.1016/S1074-7613(00)80452-5

Identifiers

DOI

1 reference

9 June 2017

1 reference